22 May 2013
Keywords: dupont, merck, revia, gains, approval, alcoholism, formerly
Article | 16 January 1995
DuPont Merck's ReVia (formerly Trexan; naltrexone) has been approved for
the treatment of alcoholism in the USA. It has already ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 January 1995
21 May 2013
© 2013 thepharmaletter.com